Louise Mannerås Holm
Isn’t it amazing that the tiny bacteria that inhabit our gut can have such an impact on our health!
My research is focused on the role of gut microbiota in metabolic health, with specific emphasis on microbial regulation of insulin sensitivity.
The gut microbiota is altered in metabolic diseases such as type 2 diabetes. However, the causality and the mechanism behind this relationship is still unclear. With my work, I want to contribute to a clearer understanding of microbial contribution to insulin resistance and type 2 diabetes. I am doing so using conventional and gnotobiotic animal models. I have long-term experience from in vivo models and during my PhD and postdoctoral work I have gained knowledge in a broad range of methods to study glucose homeostasis and insulin sensitivity. I am also focusing on getting mechanistic insight into how bariatric surgery improves metabolic disturbances associated with obesity using in vivo models.
In addition to my own research projects, I am operations manager for our gnotobiotic facility.
More about me